By KATIE THOMAS
The price set by the Swiss drugmaker Novartis may be the world’s highest for a single treatment — prompting renewed debate about how society will pay for gene-therapy breakthroughs.
Published: May 23, 2019 at 08:00PM
from NYT Health https://nyti.ms/2HYjDo2
via IFTTT
from WordPress http://bit.ly/2X52XSi
via IFTTT
No comments:
Post a Comment